Ultralife Corp (ULBI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.59 +0.01 (+0.22%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.59 unch (unch) 16:02 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 6,409 | 7,166 | -120 | -230 | 5,331 |
Depreciation Amortization | 4,248 | 3,975 | 4,495 | 3,643 | 2,986 |
Income taxes - deferred | 1,232 | 1,301 | -962 | -147 | 1,386 |
Accounts receivable | 7,599 | -3,890 | -7,881 | 4,423 | 9,211 |
Other Working Capital | 3,887 | -11,041 | -5,452 | 388 | 12,667 |
Other Operating Activity | -6,739 | 4,418 | 8,657 | -3,752 | -9,861 |
Operating Cash Flow | $16,636 | $1,929 | $-1,263 | $4,325 | $21,720 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,932 | -2,552 | -1,679 | -2,814 | -2,981 |
Net Acquisitions | -48,022 | N/A | N/A | -23,519 | N/A |
Investing Cash Flow | $-49,954 | $-2,552 | $-1,679 | $-26,333 | $-2,981 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 55,000 | 7,250 | 3,350 | 20,980 | N/A |
Common Stock Issued | 1,999 | 1,248 | 116 | 398 | 238 |
Other Financing Activity | -27,139 | -3,008 | -2,948 | -1,736 | -15,932 |
Financing Cash Flow | $29,860 | $5,490 | $518 | $19,642 | $-15,694 |
Exchange Rate Effect | 34 | -302 | -276 | 126 | 203 |
Beginning Cash Position | 10,278 | 5,713 | 8,413 | 10,653 | 7,405 |
End Cash Position | 6,854 | 10,278 | 5,713 | 8,413 | 10,653 |
Net Cash Flow | $-3,424 | $4,565 | $-2,700 | $-2,240 | $3,248 |
Free Cash Flow | |||||
Operating Cash Flow | 16,636 | 1,929 | -1,263 | 4,325 | 21,720 |
Capital Expenditure | -1,932 | -2,552 | -1,679 | -2,814 | -3,101 |
Free Cash Flow | 14,704 | -623 | -2,942 | 1,511 | 18,619 |